Vice President Harris Critiques Federal Cannabis Classification as “Absurd,” Awaits DEA Decision
NEW YORK- In a recent statement at the White House, Vice President Kamala Harris has labeled the federal classification of cannabis as “absurd,” emphasizing the administration’s anticipation for the Drug Enforcement Administration (DEA) to reconsider its categorization. The comments were made during a roundtable discussion on cannabis policy, which included Kentucky Governor Andy Beshear, individuals pardoned by President Joe Biden for low-level cannabis offenses, and rapper Fat Joe.
The Vice President expressed confidence in the DEA’s expedited efforts towards reevaluating cannabis’ current standing under the Controlled Substances Act, where it is listed as a Schedule I substance, equated with LSD and heroin. This classification denotes it as having no recognized medical use and a high potential for abuse. The ongoing review follows a recommendation from the Department of Health and Human Services (HHS) to reclassify cannabis with more than 0.3 percent THC to a less stringent category, a move that could significantly alter its legal landscape.
This dialogue arrives amid increasing public support for cannabis legalization, with recent polls indicating a 70 percent approval rate among Americans. The issue of cannabis reform is especially resonant with younger voters, a demographic the Biden administration is keen to engage as the presidential election approaches. President Biden, in his efforts to reform federal cannabis policies, has previously issued executive orders pardoning individuals with certain nonviolent federal cannabis offenses and directed the HHS to review its scheduling. In late 2023, HHS recommended a reclassification of cannabis, prompting awaited final decisions from the Department of Justice.
The Vice President’s remarks and the administration’s proactive stance on cannabis policy reform highlight a significant shift in federal perspective. With tens of thousands potentially affected by expanded pardon declarations, the administration’s actions underscore a commitment to adjusting federal cannabis policies in line with evolving public opinion and scientific understanding. As the DEA concludes its review, the nation watches closely for decisions that could redefine cannabis regulation at the federal level, marking a pivotal moment in the administration’s approach to cannabis policy ahead of the electoral cycle.